Glycerin

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation due to dryness of the eye. It serves as a lubricant to prevent further irritation and to alleviate symptoms associated with dry eyes. Additionally, this drug functions as a protectant against further irritation, providing relief from dryness of the eye.

Dosage and Administration

Healthcare professionals are advised to instill 1 to 2 drops of the medication in the affected eye(s) as needed. It is important to ensure that the dropper does not come into contact with the eye or any other surface to maintain sterility. The frequency of administration should be determined based on the clinical response of the patient.

Contraindications

Use is contraindicated in individuals who have ingested the product orally. In such cases, immediate medical assistance should be sought, or the Poison Control center should be contacted.

Warnings and Precautions

External use only. To prevent contamination, healthcare professionals should instruct patients not to touch the tip of the bottle closure to any surfaces, including the eye or skin. The solution should not be used if there is any change in color or if it becomes cloudy, as this may indicate degradation of the product.

Patients should be advised to discontinue use and contact their healthcare provider if they experience any of the following symptoms: eye pain, changes in vision, persistent redness, or irritation of the eye. Additionally, if the condition worsens or does not improve within 72 hours, medical advice should be sought.

In the event of accidental ingestion, it is critical to seek emergency medical assistance or contact a Poison Control center immediately.

Side Effects

Patients should be aware of the following adverse reactions associated with the use of this product.

Serious adverse reactions may occur, necessitating immediate medical attention. Patients are advised to stop use and consult a healthcare professional if they experience eye pain, changes in vision, continued redness, or irritation of the eye. Additionally, if the condition worsens or persists for more than 72 hours, medical advice should be sought.

It is important to note that this product is for external use only. To prevent contamination, patients should avoid touching the tip of the bottle closure to any surfaces, including the eye or skin. Furthermore, the solution should not be used if it changes color or becomes cloudy, as this may indicate a compromised product.

These precautions are essential to ensure the safety and efficacy of the treatment.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Regener-Eyes. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be informed of the absence of established safety data during pregnancy.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to nursing mothers. The effects on the nursing infant are not well studied; thus, the risks versus benefits should be considered.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should encourage patients to reach out with any questions or concerns regarding their treatment. Patients can contact the dedicated support line at (800) 781-0818 for assistance. It is important for healthcare providers to ensure that patients feel comfortable seeking clarification on their medication, potential side effects, and any other related inquiries.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are necessary beyond standard storage practices.

Additional Clinical Information

Patients and clinicians can contact the provided helpline at (800) 781-0818 for any inquiries or counseling related to the medication. No further data are available.

Drug Information (PDF)

This file contains official product information for Regener-Eyes, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)